SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-125825
Filing Date
2022-12-09
Accepted
2022-12-09 16:00:59
Documents
4
Effectiveness Date
2022-12-09

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2232326d1_s8.htm S-8 44951
2 EXHIBIT 5.1 tm2232326d1_ex5-1.htm EX-5.1 20640
3 EXHIBIT 23.1 tm2232326d1_ex23-1.htm EX-23.1 1758
4 EXHIBIT 107 tm2232326d1_ex107.htm EX-FILING FEES 9361
  Complete submission text file 0001104659-22-125825.txt   77791
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268727 | Film No.: 221454716
SIC: 2834 Pharmaceutical Preparations